Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

IRISpec" CA/CB two-part urine chemistry control twin set Recalled by Iris Diagnostics Due to The firm recalled after it received complaints of...

Date: July 9, 2012
Company: Iris Diagnostics
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Iris Diagnostics directly.

Affected Products

IRISpec" CA/CB two-part urine chemistry control twin set, Iris Diagnostics part number 800-0074. Intended Use: IRISpec CA/CB is an assayed QC material for monitoring of the urine chemistry analytes and devices as listed on the package insert. For in vitro diagnostic (IVD) use only.

Quantity: 862

Why Was This Recalled?

The firm recalled after it received complaints of IRISpec CA/CB two part Urine Chemistry Control, 101131-12, where the nitrite results read negative for the part B control, which should be positive.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Iris Diagnostics

Iris Diagnostics has 4 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report